|
ATCC
murine melanoma cell line b16f10 Murine Melanoma Cell Line B16f10, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/murine melanoma cell line b16f10/product/ATCC Average 99 stars, based on 1 article reviews
murine melanoma cell line b16f10 - by Bioz Stars,
2026-02
99/100 stars
|
Buy from Supplier |
|
Revvity
bw124734 ![]() Bw124734, supplied by Revvity, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/bw124734/product/Revvity Average 92 stars, based on 1 article reviews
bw124734 - by Bioz Stars,
2026-02
92/100 stars
|
Buy from Supplier |
|
ATCC
b16f10luc2 cells ![]() B16f10luc2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16f10luc2 cells/product/ATCC Average 95 stars, based on 1 article reviews
b16f10luc2 cells - by Bioz Stars,
2026-02
95/100 stars
|
Buy from Supplier |
|
CLS Cell Lines Service GmbH
cell culture murine melanoma b16 f10 cells ![]() Cell Culture Murine Melanoma B16 F10 Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/cell culture murine melanoma b16 f10 cells/product/CLS Cell Lines Service GmbH Average 94 stars, based on 1 article reviews
cell culture murine melanoma b16 f10 cells - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
AMS Biotechnology
b16 f10 cells ![]() B16 F10 Cells, supplied by AMS Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16 f10 cells/product/AMS Biotechnology Average 96 stars, based on 1 article reviews
b16 f10 cells - by Bioz Stars,
2026-02
96/100 stars
|
Buy from Supplier |
|
Innovative Research Inc
b16 f10 cells ![]() B16 F10 Cells, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16 f10 cells/product/Innovative Research Inc Average 91 stars, based on 1 article reviews
b16 f10 cells - by Bioz Stars,
2026-02
91/100 stars
|
Buy from Supplier |
|
Exosome Diagnostics
b16 f10 ![]() B16 F10, supplied by Exosome Diagnostics, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16 f10/product/Exosome Diagnostics Average 93 stars, based on 1 article reviews
b16 f10 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Korean Cell Line Bank
b16f10 human melanoma carcinoma cells ![]() B16f10 Human Melanoma Carcinoma Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16f10 human melanoma carcinoma cells/product/Korean Cell Line Bank Average 90 stars, based on 1 article reviews
b16f10 human melanoma carcinoma cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
COLD SPRING BIOTECH CORP
firefly luciferase-expressing b16f10 melanoma cells ![]() Firefly Luciferase Expressing B16f10 Melanoma Cells, supplied by COLD SPRING BIOTECH CORP, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/firefly luciferase-expressing b16f10 melanoma cells/product/COLD SPRING BIOTECH CORP Average 90 stars, based on 1 article reviews
firefly luciferase-expressing b16f10 melanoma cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
BioResource International Inc
b16f10 murine melanoma cells ![]() B16f10 Murine Melanoma Cells, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16f10 murine melanoma cells/product/BioResource International Inc Average 90 stars, based on 1 article reviews
b16f10 murine melanoma cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Jackson Laboratory
b16-f10 cells ![]() B16 F10 Cells, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16-f10 cells/product/Jackson Laboratory Average 90 stars, based on 1 article reviews
b16-f10 cells - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Amorepacific Corporation
b16f10 ![]() B16f10, supplied by Amorepacific Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/b16f10/product/Amorepacific Corporation Average 90 stars, based on 1 article reviews
b16f10 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Cell reports
Article Title: Chronic stress physically spares but functionally impairs innate-like invariant T cells
doi: 10.1016/j.celrep.2021.108979
Figure Lengend Snippet:
Article Snippet: Mouse: B16-F10-Red-FLuc (B16-FLuc) melanoma cells ,
Techniques: Control, Recombinant, Western Blot, Enzyme-linked Immunosorbent Assay, Staining, In Situ, Selection, cDNA Synthesis, Software
Journal: Journal of controlled release : official journal of the Controlled Release Society
Article Title: Surface Engineering Tumor Cells with Adjuvant-loaded Particles for Use as Cancer Vaccines
doi: 10.1016/j.jconrel.2016.12.036
Figure Lengend Snippet: (A1) B16.F10 cells and (A2) RM11 cells treated or not treated (control) with biotinylated anti-CD29 antibodies (anti-CD29-biotin) followed by strepavidin-PE. (B–F) Validation of cell-particle hybrid assembly from B16.F10 or RM11 cells subsequent to surface biotinylation using anti-CD29-biotin and mixed with streptavidin-coated particles loaded with rhodamine B and washed to remove unbound particles (hybrid). Control involved the same conditions except cells were not treated with anti-CD29-biotin. Validation was performed using: (B1–2 and E1–2): flow cytometry where (B1 and E1) representive (n = 1) and (B2 and E2) mean (n = 3) results from measuring relative mean rhodamine fluorescence intensity (RMFI(Rh)) of (B1 and B2) B16.F10 and (E1 and E2) RM11 cells; (C1–2 and F1–2): laser scanning confocal microscopy showing (C1 and F1) hybrid and (C2 and F2) control cell-particle mixtures for (C1 and C2) B16.F10 and (F1 and F2) RM11 cells (blue = DAPI stained cell nuclei, red = rhodamine-labeled PLGA particles); (D): scanning electron microscopy showing (D1) B16.F10 hybrid and (D2) control cell-particle mixtures (arrows in C1, D1, and F1 indicate particles bound to cell surface). Scale bar= 20 micron for C1–2 and F1–2, 10 microns for D1–2. When applicable, error bars = SD. ** p < 0.01, *** p < 0.001, n = 3.
Article Snippet: For vaccinations, a B16.F10 GM-CSF clone expressing 220 ng GM-CSF/10 6 cells/day was derived by transducing
Techniques: Flow Cytometry, Fluorescence, Confocal Microscopy, Staining, Labeling, Electron Microscopy
Journal: Journal of controlled release : official journal of the Controlled Release Society
Article Title: Surface Engineering Tumor Cells with Adjuvant-loaded Particles for Use as Cancer Vaccines
doi: 10.1016/j.jconrel.2016.12.036
Figure Lengend Snippet: Laser scanning confocal microscopy imaging of cell-particle hybrid uptake by BMDC. Cell-particle hybrids were incubated with BMDC Yellow arrows indicating colocalization of B16.F10 cells (green) and particles (red) inside BMDC (magenta). Magenta: Alexa flour®700 (CD11c) stained BMDC, green: CFSE labeled B16.F10 melanoma cells, red: rhodamine B-labeled PLGA particles, gray: DAPI stained cell nuclei. Scale bar: 20 micron.
Article Snippet: For vaccinations, a B16.F10 GM-CSF clone expressing 220 ng GM-CSF/10 6 cells/day was derived by transducing
Techniques: Confocal Microscopy, Imaging, Incubation, Staining, Labeling
Journal: Drug Design, Development and Therapy
Article Title: Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells
doi: 10.2147/DDDT.S58414
Figure Lengend Snippet: Characterization of EGCG-pNG versus cell viabilities after 24 hours of treatment
Article Snippet:
Techniques: Zeta Potential Analyzer
Journal: Drug Design, Development and Therapy
Article Title: Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells
doi: 10.2147/DDDT.S58414
Figure Lengend Snippet: The effects of EGCG and pNG on Vero and B16F10 cell proliferation. Notes: ( A ) Cells were treated with or without increasing concentrations of EGCG for 24 hours; ( B ) cells were treated with or without increasing concentrations of pNG for 24 hours. Data shown are means ± standard deviations for three samples. Data containing asterisks are significantly different from the control values at ** P <0.01, *** P <0.001. Abbreviations: EGCG, (–)-epigallocatechin-3-gallate; pNG, physical nanogold.
Article Snippet:
Techniques: Control
Journal: Drug Design, Development and Therapy
Article Title: Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells
doi: 10.2147/DDDT.S58414
Figure Lengend Snippet: Improving anti-proliferative activity of EGCG and pNG in vitro. Notes: ( A ) Morphologies of B16F10 cells treated with or without 25–50 μM EGCG and/or 1.25–2.5 ppm pNG for 24 hours (magnification ×40). Scale bar, 100 μm; ( B ) All the mixtures of EGCG and pNG underwent ultrasound pretreatment and showed significant 24-hour cytotoxicity compared with pNG or EGCG, respectively, in B16F10 but not Vero cells; ( C ) improved cytotoxicity of the EGCG and pNG mixtures was only achieved with ultrasound pretreatment; this was not observed in the mixture without ultrasound pretreatment. The cell viabilities were determined via WST-8 assay. Data shown are mean ± standard deviation for three samples. Data containing asterisks are significantly different from the control values at ** P <0.01; *** P <0.001. Abbreviations: EGCG, (–)-epigallocatechin-3-gallate; pNG, physical nanogold; E25, EGCG 25 μM; E50, EGCG 50 μM; P1.25, pNG 1.25 ppm; P2.5, pNG 2.5 ppm; E25–P1.25, EGCG-pNG 25 μM:1.25 ppm; E50–P2.5, EGCG-pNG 50 μM:2.5 ppm.
Article Snippet:
Techniques: Activity Assay, In Vitro, Standard Deviation, Control
Journal: Drug Design, Development and Therapy
Article Title: Improving anticancer efficacy of (–)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells
doi: 10.2147/DDDT.S58414
Figure Lengend Snippet: Enhanced apoptosis induction of EGCG by pNG in B16F10 cells. Notes: ( A ) The fractions of annexin V-positive B16F10 cells were 3.59%±0.30%, 12.63%±0.61%, 20.93%±0.55%, and 25.7%±0.54%, after treatment with pNG 2.5 ppm, EGCG 50 μM, EGCG-pNG 50 μM:2.5 ppm, and Taxol ® (Sigma-Aldrich; St Louis, MO, USA) 0.5 μM, respectively, at 24 hours; ( B ) the fractions of annexin V-positive and PI-negative B16F10 cells were 1.0% ± 0.17%, 3.2% ± 0.23%, 6.5% ± 0.23%, and 11.7% ± 0.41%, after treatment with pNG 2.5 ppm, EGCG 50 μM, EGCG-pNG 50 μM:2.5 ppm, and Taxol ® 0.5 μM, respectively, at 24 hours; ( C ) cells treated with EGCG-pNG for 24 hours expressed more green fluorescence than those treated with EGCG (magnification ×200). Depolarized mitochondria are indicated by green fluorescence (JC-10 monomer), and polarized mitochondria are indicated by orange fluorescence (aggregated JC-10). Cell nuclei are indicated by blue fluorescence coupled with Hoechst 33342 staining. Scale bar, 10 μm; ( D ) cells treated with EGCG-pNG for 24 hours showed a significant increase of caspase-3, -8, and -9 activity compared with those treated with EGCG; ( E ) initiation of time-dependent apoptotic activation by EGCG-pNG treatment via the caspase pathway in B16F10 melanoma cells. Data shown are mean ± standard deviation for three samples. Data containing asterisks are significantly different from the control values at * P <0.05; ** P <0.01; *** P <0.001. Abbreviations: PI, propidium iodide; EGCG, (–)-epigallocatechin-3-gallate; pNG, physical nanogold; P2.5, pNG 2.5 ppm; E50, EGCG 50 μM; E50-P2.5, EGCG-pNG 50 μM:2.5 ppm; ZVAD, Z-VAD-FMK, N-Benzyloxycarbonyl-Val-Ala-Asp (O-Me) fluoromethyl ketone.
Article Snippet:
Techniques: Fluorescence, Staining, Activity Assay, Activation Assay, Standard Deviation, Control